Serotonin syndrome in advanced cancer patient treated with tramadol and antidepressants
Abstract
Serotonin syndrome is potentially life-threatening syndrome associated with excessive serotonergic activity
within the central nervous system. Serotonin syndrome is associated with medication use, drug interactions,
and overdose. While serotonin syndrome is often associated with the use of selective serotonin inhibitors
(SSRI), an increasing number of reports are being presented involving the use of tramadol. With tramadol
increasing popularity, the goal of this article is to make physicians more alert and aware of this potential
side effect. Serotonin syndrome may be difficult to diagnose. A case of serotonin syndrome caused by the
combination of tramadol and antidepressants in a patient with advanced cancer is presented and discussed.
The importance of early diagnosis of this syndrome is emphasized.
Palliat Med Pract 2019; 13, 3: 161–164
Keywords: tramadoltoxicityserotonin syndromeantidepressants
References
- Minami K, Sudo Y, Miyano K, et al. µ-Opioid receptor activation by tramadol and O-desmethyltramadol (M1). J Anesth. 2015; 29(3): 475–479.
- Gibbison B, Bailey CR, Klein AA. Tramadol - the Marmite(™) drug. Anaesthesia. 2015; 70(2): 125–130.
- Kirchheiner J, Keulen JTHA, Bauer S, et al. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. J Clin Psychopharmacol. 2008; 28(1): 78–83.
- Picco G, Ríos R. Interacciones medicamentosas: el tan ignorado síndrome serotoninérgico. Medicina Paliativa. 2018; 25(4): 301–302.
- Anderson T, Watson MS, Marr K. Serotonin syndrome: A hidden danger in palliative care. Eur J Palliat Care. 2005; 12: 97–100.
- Wiffen PJ, Derry S, Moore SA. Tramadol with or without paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev. 2017; 16(5): CD012508.
- Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29(4): 149–174.
